surmount-1 trial tirzepatide weight loss non-diabetic Gastrointestinal tolerability and reduction associated with in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT‐1 to ‐4 trials - Rubino - 2025 Weight reduction with different doses

A 68-week trial published in the New England Journal of Medicine showed that participants taking semaglutide lost an average of 14% of their body weight, compared to a 3% loss in the placebo group

Mix Pharmacy has been compounding medications at our Oakdale, MN location for 15 years

Key Benefits: Supports soft tissue and joint resilience Helps maintain gastrointestinal comfort and mucosal integrity Promotes nitric oxide and redox balance Utilizes LipoEmulsion technology for ingredient stability Precision spray delivery for consistent dosing How It Works: BPC-Lx Pro delivers a calibrated pentadecapeptide as short-chain amino acids suspended in a lipid-based LipoEmulsion system

Protein expression pattern similarity was quantified as 100% - (% of significantly differentiated proteins)

If you have a slow thyroid, its also important to check iodine levels before increasing iodine intake

We believe everyone deserves access to safe, supportive medical care that accounts for their unique needs, not those of others